Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Deferasirox
- Therapeutic area
- Hematology & thrombosis
- Drug class
- Iron chelators
- ATC
- V03AC
- Strength
- 360 mg
- Dosage form
- Tablet
- Pack
- 30's
- Registration no.
- 124146
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-15 03:06
Manufacturer
Solaris Life Sciences Private Limited,
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Referox (Deferasirox) is used for
Deferasirox is an iron chelator. It grabs onto extra iron in the body so the body can get rid of it, mostly in the stools (poo). Extra iron builds up in people who need many blood transfusions, because the body has no natural way to remove it, and over time it can damage the liver and heart. Deferasirox is a prescription medicine that is started and checked by specialists. It is taken by mouth as tablets, granules, or tablets that are dissolved in a drink. These forms are absorbed differently and cannot be swapped for one another without the doctor's advice.
- Long-term iron overload in people who have many blood transfusions, such as people with beta thalassaemia major
- Iron overload from blood transfusions in other types of anaemia, when deferoxamine (another iron-removing medicine) is not suitable or has not worked
- Iron overload in thalassaemia that does not need regular transfusions (non-transfusion-dependent thalassaemia), in children aged 10 and over and adults
- It can be used in children aged 2 and over who have regular transfusions
Get medical help straight away if
- Get emergency help for signs of a severe allergic reaction: swelling of the face, lips, tongue, throat or eyes, a hoarse voice, or trouble breathing or swallowing.
- Get emergency help if you vomit blood or something that looks like coffee grounds, or pass black, tarry or bright red stools. These can be signs of bleeding in the stomach or gut.
- Stop taking it and contact a doctor straight away for a serious skin reaction: a spreading rash, blisters or peeling skin, especially with fever or swollen glands.
- Stop and contact a doctor straight away if you pass much less urine than normal, or have swollen ankles or legs, extreme tiredness, shortness of breath or confusion. These can be signs of kidney damage.
Side effects, warnings and interactions for Deferasirox
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
About Referox 360 mg tablet
Referox 360 mg tablet contains Deferasirox 360 mg. It is registered with DRAP by Solaris Life Sciences Private Limited (registration no. 124146). Its official price is PKR 18,645.86 for a pack of 30's, about PKR 621.53 per tablet. This price has applied since 23 July 2026. Referox is also available as 180 mg tablet, 250 mg tablet and 500 mg tablet. 2 other brands of Deferasirox 360 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other strengths of Referox
All 2 other brands of Deferasirox 360 mg tablet in Pakistan
These 2 brands are alternatives (substitutes) to Referox: each contains Deferasirox 360 mg tablet. Ask your doctor or pharmacist before you switch brands.
Sorted by price per tablet, lowest first. The lowest is Arefed (Genome Pharmaceuticals (Pvt.) Ltd) at PKR 397 per tablet; the highest is Oleptiss at PKR 539. All prices are official DRAP prices.
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Referox, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Solaris Life Sciences Private Limited,, Rawat
- DRAP registration
- 124146
- infosls.rcci@gmail.com
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (30's). Current price PKR 18,645.86, effective 23 Jul 2026.
Cite this price history
MedInfoBase. Referox 360 mg, 30's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/referox-360-mg-124146-30s-solaris-life-sciences-private-limited/ (accessed 15 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 18,645.86 | 2026-07-23 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 124146Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.